Sano Takanori, Izuishi Kunihiko, Takebayashi Ryusuke, Akamoto Shintaro, Kakinoki Keitaro, Okano Keiichi, Masaki Tsutomu, Suzuki Yasuyuki
Department of Surgery, Takamatsu Hospital, Kagawa, Japan.
Hepatogastroenterology. 2011 Nov-Dec;58(112):2067-70. doi: 10.5754/hge11188.
BACKGROUND/AIMS: Despite recent development of therapeutic strategies for intrahepatic lesions, standard guidelines for treatment of extrahepatic metastases of hepatocellular carcinoma have not been established.
Surgical resection for intra-abdominal extrahepatic metastases of hepatocellular carcinoma was performed on 10 patients at our institution between 1992 and 2008. We retrospectively examined the clinicopathologic features and significance of a surgical approach in these patients.
Nine of the 10 patients received treatment for primary hepatocellular carcinoma before surgery for intra-abdominal extrahepatic metastasis. A simultaneous intrahepatic lesion was detected in half of the patients when the extrahepatic metastasis was resected. Extrahepatic recurrent organs included adrenal glands, lymph nodes, abdominal wall, stomach and diaphragm. The mean survival period after resection was 36.1 months. Two patients are still alive without further recurrence. One patient died of retroperitoneal recurrence and 7 died of intrahepatic recurrence or liver failure after resection.
With careful case selection, considering that not all extrahepatic metastases suggest systemic spread of hepatocellular carcinoma, surgical treatment for metastatic lesions in the abdominal cavity can provide a relatively good prognosis.
背景/目的:尽管近期针对肝内病变的治疗策略有所发展,但肝细胞癌肝外转移的标准治疗指南尚未确立。
1992年至2008年间,我们机构对10例肝细胞癌腹腔内肝外转移患者进行了手术切除。我们回顾性研究了这些患者的临床病理特征以及手术方法的意义。
10例患者中有9例在接受腹腔内肝外转移手术前接受了原发性肝细胞癌的治疗。在切除肝外转移灶时,半数患者同时发现肝内病变。肝外复发器官包括肾上腺、淋巴结、腹壁、胃和膈肌。切除后的平均生存期为36.1个月。2例患者仍存活且无进一步复发。1例患者死于腹膜后复发,7例患者死于切除后的肝内复发或肝功能衰竭。
通过仔细的病例选择,考虑到并非所有肝外转移都提示肝细胞癌的全身播散,对腹腔内转移灶进行手术治疗可提供相对较好的预后。